ABCELLERA BIOLOGICS INC (ABCL) Stock Income Statement
USA - NASDAQ:ABCL - CA00288U1066 - Common Stock
3.62 USD
-0.35 (-8.82%)
3.6398 USD
+0.02 (+0.55%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 35.32M | 28.83M | 38.02M | 485.40M | 375.20M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 296.60M | 343.60M | 275.23M | 268.90M | 170.80M | |||
| Research and Development | 182.81M | 167.26M | 175.66M | 107.90M | 62.10M | |||
| Selling, General, and Administrative Expenses | 85.18M | 85.49M | 75.18M | 66.80M | 48.80M | |||
| Operating Income | -261.28M | -314.77M | -237.21M | 216.50M | 204.40M | |||
| Interest Income/Expense | 48.48M | 55.87M | 46.15M | 12.00M | -2.80M | |||
| Other Income/Expense | 7.88M | 58.50M | 17.03M | 10.60M | 17.50M | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -204.93M | -200.40M | -174.03M | 239.10M | 219.10M | |||
| Income Tax | -33.25M | -37.54M | -27.63M | 80.60M | 65.70M | |||
| Net Income | -171.68M | -162.86M | -146.40M | 158.50M | 153.50M | |||
| EBITDA | -237.48M | -223.92M | -212.81M | 244.40M | 218.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.5765 | -0.5533 | -0.5063 | 0.5 | 0.48 | |||
| Non GAAP EPS | -0.57 | -0.55 | -0.52 | 0.5 | 0.47 | |||
| Statistics | ||||||||
| Profit Margin | -486.01% | -564.83% | -385.00% | 32.65% | 40.91% | |||
| Operating Profit Margin | -739.66% | -1091.69% | -623.82% | 44.60% | 54.48% | |||
All data in USD